MASIMO CORP — Director's Dealing 2019

Jun 18, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MASIMO CORP (MASI)
CIK: 0000937556
Period of Report: 2019-06-14

Reporting Person: Sampath Anand (EVP, Ops & Clinical Research)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-06-14	Common Stock	M	15000	$28.03	Acquired	27518	Direct
2019-06-14	Common Stock	S	15000	$142.38	Disposed	12518	Direct
2019-06-14	Common Stock	M	15000	$28.03	Acquired	27518	Direct
2019-06-14	Common Stock	S	15000	$142.39	Disposed	12518	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-14	Non-Qualified Stock Option (Right to Buy)	$28.03	M	15000	Disposed	2024-02-18	Common Stock (15000.0)	Direct
2019-06-14	Non-Qualified Stock Option (Right to Buy)	$28.03	M	15000	Disposed	2024-02-18	Common Stock (15000.0)	Direct

Footnotes

F1: The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of May 29, 2019, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.

F2: The price reported in Column 4 represents the weighted average sales price per share. The actual sales prices ranged from a low of $140.79 per share to a high of $144.45 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: The price reported in Column 4 represents the weighted average sales price per share. The actual sales prices ranged from a low of $140.79 per share to a high of $144.44 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This option was granted on February 18, 2014 and is exercisable as the option vests. This option vested over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.